Literature DB >> 33818348

COVID-19 research priorities for non-pharmaceutical public health and social measures.

Jan C Semenza1, Cornelia Adlhoch1, Agoritsa Baka1, Eeva Broberg1, Orlando Cenciarelli1, Stefania De Angelis1, Margot Einoder-Moreno1, Irina Jovel Quinonez Dalmau1, Pete Kinross1, John Kinsman1, Katrin Leitmeyer1, Angeliki Melidou1, Howard Needham1, Diamantis Plachouras1, Emmanuel Robesyn1, Senia Rosales-Klintz1, Jonathan E Suk1, Carl Suetens1, Klaus Weist1, Andrea Würz1, Pasi Penttinen1.   

Abstract

Europe is in the midst of a COVID-19 epidemic and a number of non-pharmaceutical public health and social measures have been implemented, in order to contain the transmission of severe acute respiratory syndrome coronavirus 2. These measures are fundamental elements of the public health approach to controlling transmission but have proven not to be sufficiently effective. Therefore, the European Centre for Disease Prevention and Control has conducted an assessment of research gaps that can help inform policy decisions regarding the COVID-19 response. We have identified research gaps in the area of non-pharmaceutical measures, physical distancing, contact tracing, transmission, communication, mental health, seasonality and environment/climate, surveillance and behavioural aspects of COVID-19. This prioritisation exercise is a step towards the global efforts of developing a coherent research road map in coping with the current epidemic but also developing preparedness measures for the next unexpected epidemic.

Entities:  

Keywords:  COVID-19

Year:  2021        PMID: 33818348     DOI: 10.1017/S0950268821000716

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  3 in total

1.  One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk.

Authors:  Christine Klein; Max Borsche; Alexander Balck; Bandik Föh; Johann Rahmöller; Elke Peters; Jan Knickmann; Miranda Lane; Eva-Juliane Vollstedt; Susanne A Elsner; Nadja Käding; Susanne Hauswaldt; Tanja Lange; Jennifer E Hundt; Selina Lehrian; Julia Giese; Alexander Mischnik; Stefan Niemann; Florian Maurer; Susanne Homolka; Laura Paulowski; Jan Kramer; Christoph Twesten; Christian Sina; Gabriele Gillessen-Kaesbach; Hauke Busch; Marc Ehlers; Stefan Taube; Jan Rupp; Alexander Katalinic
Journal:  Sci Adv       Date:  2022-04-15       Impact factor: 14.136

2.  The impact of non-pharmaceutical interventions on COVID-19 cases in South Australia and Victoria.

Authors:  Adriana Milazzo; Lynne Giles; Natalie Parent; Sophie McCarthy; Caroline Laurence
Journal:  Aust N Z J Public Health       Date:  2022-05-12       Impact factor: 3.755

3.  Strengthening the evidence base for decisions on public health and social measures.

Authors:  Delia Enria; Zijian Feng; Atle Fretheim; Chikwe Ihekweazu; Trygve Ottersen; Anne Schuchat; Kumnuan Ungchusak; Sylvie Briand; Victoria Haldane; Jaya Lamichhane; Ramona Ludolph; Margaux Mathis; Tim Nguyen; Nahoko Shindo
Journal:  Bull World Health Organ       Date:  2021-09-01       Impact factor: 9.408

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.